Form 4: Mesa Laboratories CFO John Sakys Reports Stock Option Expiration
SEC Form 4 Filing
CFO of Mesa Laboratories, John Sakys, reports the expiration of unexercised non-qualified stock options.
Summary
- On April 3, 2024, John Sakys, CFO of Mesa Laboratories, filed a Form 4.
- The form reports the expiration of 2,500 non-qualified stock options (NSOs) on April 2, 2024.
- These options had an exercise price of $142.40.
- The options were granted on April 2, 2018, and vested in increments of 1/5 on each anniversary of the grant date.
- Sakys directly owns 23,793 shares of Mesa Laboratories common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock option expiration, which has a neutral sentiment.
Industry Context
This is a standard SEC filing related to executive compensation and stock ownership. It doesn't necessarily reflect broader industry trends.
Key Dates
| Date | Description |
|---|---|
| 04/02/2018 | Grant date of the non-qualified stock options |
| 04/02/2019 | First vesting date of the non-qualified stock options |
| 04/02/2024 | Expiration date of the non-qualified stock options |
| 04/03/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.